INDICAID® Fentanyl Rapid Detection Test

Detect fentanyl in powder samples in one minute with more than 99% accuracy. Designed to support harm reduction, rehabilitation, and community safety programs.

For harm reduction use
Results in 1 minute
>99% accuracy at 50% above and 50% below the cut-off
Ultra-sensitive: 10 ng/mL cut-off
No instrument required
Supports community harm reduction and safety screening

About

The INDICAID Fentanyl Rapid Detection Test is a rapid chromatographic immunoassay for the qualitative detection of fentanyl in powder at a cut-off concentration of 10 ng/mL. This test provides a preliminary result for harm reduction, rehabilitation, and community safety use.

Features

Results after 1 minute
>99% accuracy and 10 ng/mL sensitivity
Detects fentanyl in powder form
No instruments required
Simple, three-step workflow

Who it's for

Harm reduction programs – Community groups and non-profits supporting safer substance use and drug-checking efforts.
Public health departments – Local and state agencies addressing opioid-related harm.
Rehabilitation and recovery centers – Facilities supporting substance use treatment and safety screening.
Clinical and academic researchers – Professionals studying contamination, drug trends, and harm reduction efficacy.

Ready to learn more?

Contact sales or request a sample

Specifications

Contents	Individually wrapped test strips, instructions for use, quick reference guide
Tests per kit	50 / Custom
Specimen type	Powder diluted in water
Time to result	1 minute
Cut-off concentration	10 ng/mL
Sensitivity	>99% accuracy at 50% above and 50% below cut-off concentration
Storage condition	Store at 35-86°F (2-30°C); do not freeze; keep dry and away from sunlight
Shelf life	24 months

Intended use

The INDICAID Fentanyl Rapid Detection Test is a rapid screening test that detects fentanyl in powder samples without the use of laboratory instruments.
The test uses an antibody to selectively detect fentanyl at concentrations exceeding 10 ng/mL.

This assay provides a preliminary qualitative result. A confirmatory analytical method, such as Gas Chromatography/Mass Spectrometry (GC/MS), should be used to verify results. Clinical judgment should be applied to any drug-of-abuse test result, particularly when interpreting preliminary positives.